Ciprofloxacin
Product Images NDC 67296-0237

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 67296-0237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cipro1 (Cipro1)

Chemical structure of Ciprofloxacin hydrochloride monohydrate shown as a 2D molecular diagram including fluorine, carboxylic acid, piperazine, and cyclopropyl groups.*

FDA Label Image

Cipro2 (Cipro2)

Chemical structure diagram of Ciprofloxacin, showing the molecular arrangement including fluorine substitution, a piperazine ring, and a carboxylic acid group, consistent with the active ingredient Ciprofloxacin as labeled.*

FDA Label Image

Cipro250 (Doc20180615160347 001)

Three Ciprofloxacin 250 mg tablet labels from RedPharm Drug, Inc. Each label shows the product name, strength, and prescription-only status. The labels indicate different tablet counts: 6, 14, and 10 tablets. Manufacturer is Dr. Reddy's Laboratories Limited, India. Storage instructions note controlled room temperature. Each label includes lot numbers, barcode, and distributor information for Eden Prairie, MN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.